<DOC>
	<DOCNO>NCT00958464</DOCNO>
	<brief_summary>The purpose study determine whether Perthes ' disease cause detectable hip cartilage damage young people reach heal stage disease .</brief_summary>
	<brief_title>The Effect Perthes ' Disease Hip Cartilage</brief_title>
	<detailed_description>We recruit 20 subject heal Perthes ' population . We use dGEMRIC imaging identify region cartilage degeneration femur acetabulum . Both hip image use unaffected side control . We apply dGEMRIC imaging , allow composition cartilage ( specifically , concentration glycosaminoglycans [ GAGs ] , important structural protein cartilage ) assess . The MRI protocol consist intravenous injection 0.4 ml/kg dose gadopentetate dimeglumine 2- [ Gd-DTPA2- ] contrast agent ( Magnevist , Bayer ) 90 minute prior image . Due need image within relatively narrow window time , hip subject must image separate day . The subject ask walk 10 minute receive contrast agent injection facilitate equilibration contrast agent hip joint . The scan perform UBC 's High Field Imaging Centre 3T Phillips Intera scanner . Dr. Wilson access scanner research . The scan protocol follow : 3D IR-TFE sequence TR/TE/Flip 4.7 ms/1.6 ms/30 seven inversion time ; 1600 , 1200 , 800 , 400 , 200 , 300 , 100 ms. In-plane resolution 0.7 mm slice thickness 3 mm . Total imaging time approximately 1 hour ( visit ) . The T1 calculate image obtain use validate , custom write software ( IGOR ) . The resulting image provide map approximate glycosaminoglycan concentration , consequently , cartilage degeneration . The MRI do sedation . MRIs perform sedation BCCH child age seven . Subjects study age 7 18 . The contrast agent , Gd-DTPA2- routinely use child clinical setting . Radiographs use comparison obtain part standard care follow-up protocol .</detailed_description>
	<mesh_term>Legg-Calve-Perthes Disease</mesh_term>
	<criteria>Subjects must reach healed stage unilateral Perthes ' disease . Subjects 7 18 year age . Subjects must understand English . Subjects exclude bilateral Perthes ' disease yet reach healing stage disease . Subjects also exclude meet criterion MRI ( e.g. , subject metal implant , claustrophobic , metallic object eye pacemaker ) . A subject exclude precaution MR contrast agent , Magnevist , pregnancy , breastfeeding , respiratory allergy , asthma , thrombotic syndrome , history grand mal seizure , impair renal hepatic function .</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>MRI</keyword>
	<keyword>Perthes'disease</keyword>
	<keyword>hip</keyword>
	<keyword>cartilage</keyword>
</DOC>